Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. - Wikidata - awgldk - TriplyDB

Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius.

Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius.

http://www.wikidata.org/entity/Q40042183

about

Adipokines, metabolic syndrome and rheumatic diseases Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort.Prevalence and gender distribution of the metabolic syndrome Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia Description and prediction of the development of metabolic syndrome: a longitudinal analysis using a markov model approach Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.Gender-specific association between tobacco smoking and central obesity among 0.5 million Chinese people: the China Kadoorie Biobank Study.Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.Plasma Proteomic Signature in Overweight Girls Closely Correlates with Homeostasis Model Assessment (HOMA), an Objective Measure of Insulin Resistance.The influence of hip circumference on the relationship between abdominal obesity and mortality.The metabolic syndrome in thyroid disease: A report from Nigeria A closer look at the role of urotensin II in the metabolic syndrome.Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.Paternal metabolic and cardiovascular risk factors for fetal growth restriction: a case-control study.What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway.A Review of Epigenetic Markers of Tobacco and Alcohol Consumption.Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study.Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-Up Study from the Norwegian Tromsø Study.Does sustained weight loss reverse the metabolic syndrome?Role of dietary beta-glucans in the prevention of the metabolic syndrome.Rodent animal models: from mild to advanced stages of diabetic nephropathy.The risk of metabolic syndrome in women with previous GDM in a long-term follow-up.Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.High-flow-mediated constriction in adults is not influenced by biomarkers of cardiovascular and metabolic risk.Physical activity in adolescence and abdominal obesity in adulthood: a case-control study among women shift workers.Frequency of metabolic syndrome in patients with knuckle pads.Effect of changes in waist circumference on metabolic syndrome over a 6.6-year follow-up in Tehran.Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.One year follow-up of patients with screen-detected metabolic syndrome in primary care: an observational study.Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial.Optimizing waist circumference cut-points for the metabolic syndrome in a South African cohort at 3-year follow-up: the SABPA prospective cohort.Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study).Cut-points for waist circumference in Europids and South Asians.Importance of proper scaling of aerobic power when relating to cardiometabolic risk factors in children.A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria.

P2860

Q26865268-AE583838-DC03-4001-942E-608597C0D4B8 Q33651745-3068975C-CDCE-4A88-855E-D12BCFD4A36F Q33721267-EEF781E4-91B7-4AFF-A4FC-488494161792 Q34245617-E9EDCAB7-D884-467E-B2AF-8A09D96243B3 Q34404827-3E3A6606-4D46-4DC5-9283-2DBA4BA232E4 Q34608259-517C280A-E626-4DCF-83F8-8158F6DD4BE4 Q34807354-3BD7076B-6495-4825-ADEB-0AA5C7097AA9 Q34839402-B083CE9B-7C79-4AFD-8749-A9DCD29E8A2A Q35045850-FF6761BF-2911-49C6-ACC0-CF6264C7A33D Q35515756-3ED18D62-7D30-4F3D-8A9C-14A7B3310E5B Q35666503-5A506D0B-640C-4310-A153-D102255E4C82 Q35841685-893F8866-7BBD-45C8-AEDF-4F2D3B639469 Q35883636-5234ED9D-2E9A-4F40-9E4B-63346F0B85FD Q35967802-544FF8AC-AF31-4DB4-972F-1B89123A8DAA Q36492706-1C5D77BE-5D58-472A-8900-7F4341D24FA0 Q36512836-CA6C2B78-7BBD-42D4-B335-5C3AB402ED10 Q36868226-800D2D4A-A3D5-4BC3-A307-25511273F154 Q36932044-420E676B-E8BB-44EF-9AFD-0EABAA01A508 Q37073269-127D1DAD-3AE9-4EBC-B073-5BDC3CC8E56F Q37292559-0D704B21-2806-4CFA-B546-2585538DFF37 Q37394438-A5479DCA-946B-4BA4-BCE9-248B4DB1A3BA Q37729747-6CA736F1-AEFB-489C-B971-CB44EFCE693E Q37910060-9D50C75D-BFD0-417E-A690-4FC65356427D Q38029799-C40C1468-EB3A-4262-A987-1481868B4B2E Q38242389-0DD00FA6-919B-4B9F-9C5E-7B439B57353A Q38834164-E2AFE124-52F1-4AA0-B326-8497BF6A038B Q38935290-46DAE1F5-61C8-455E-9B67-8A6127CEF2E6 Q39522572-A8294EE2-5897-4D94-BB8A-117FE253ADF7 Q41039822-E7660B7F-65E6-4920-B710-17A251E583A2 Q41633723-440ABAF8-4072-43BE-9D60-08FBC2AE2E9C Q43059208-8614E9A9-3781-4D13-B28F-70BBD275F6B2 Q43105424-26EF04FB-843E-4514-A085-A06194613BD3 Q43470085-5E0712F8-7EED-42B4-9BFA-B4A705376CAF Q43710316-1CB9C1FD-63AE-497F-9438-7620930E31B9 Q46836107-26AA0778-0029-4D4C-AFC8-9002983ADCE9 Q47190358-46EBBC12-65C5-4030-BD9F-7686C9957C0C Q51139801-C3F845C0-0988-49E2-B6B5-5C42C4367DD8 Q51370879-F5263B8C-2FEF-4C82-91AA-5F19D0D3BFC6 Q54440700-7568D2AC-4275-4D7A-BC8B-6118D2E1172C Q55203101-687C3005-3FDE-4A7B-B73A-D539D5CC45E4

P2860

Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius.

http://www.wikidata.org/entity/Q40042183

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Central obesity as a precursor ...... e AusDiab study and Mauritius.

@en

type

label

Central obesity as a precursor ...... e AusDiab study and Mauritius.

@en

prefLabel

Central obesity as a precursor ...... e AusDiab study and Mauritius.

@en

P1433

Q40042183-65709B4E-DC50-4205-A195-BC734BB104A8

P1476

Q40042183-CFE72D2D-429E-4294-B50D-334355802EC4

P2093

Q40042183-25D95087-8D8E-43DC-8CC1-1C0F0F5EA1D7

Q40042183-55C60338-EB21-407A-9DFC-CB3675354B30

Q40042183-791D78D0-24E3-4B28-88F9-E02C0A10237B

Q40042183-9F59557D-5FE7-429A-B125-08C44C826606

Q40042183-CBC20D9D-98E0-472D-9D65-89CE7917A91D

P2860

Q40042183-07BBF05F-EB58-4307-82A3-D3F8E732688D

Q40042183-0CC7BB8B-6DE7-4C2A-ACE1-A8068653BC85

Q40042183-0FCB93DE-4833-4C5B-833E-906B6DD8348A

Q40042183-11A72799-F9F3-4366-B6F0-02ED69556E71

Q40042183-1573F57D-7429-4577-B82F-042F7B9F2F05

Q40042183-1A76A82A-402B-427A-AC23-B1B61B898ADA

Q40042183-1E610449-44E5-4C14-ABBF-F79C0E9F0175

Q40042183-29112BB7-5119-496B-BACE-F26837D8CCC4

Q40042183-29982605-D089-41F5-95EA-513FFBF95B1A

Q40042183-2F24B686-F363-411F-A442-211923505881

P304

Q40042183-66154358-8154-428E-B296-63E72C0CB9E1

P31

Q40042183-ED761078-A749-461B-8FA2-E5CE18A0F627

P356

Q40042183-063BDB53-0078-4795-B5C7-C6F274C98279

P433

Q40042183-FC401DBE-3169-4615-9F2A-FC1977EBE127

P478

Q40042183-1E751672-8AAD-490C-AC53-897E1D5FCBA2

P50

Q40042183-6C048275-EFB7-451A-8CB3-53D0C8E7CE49

Q40042183-D8EE188B-D5C9-4C18-995E-F5D380519D6D

Q40042183-F9F48587-0227-4447-B076-3286037A8846

Q40042183-FB0F30FD-F2A9-4057-8873-04BCED7F74E7

P577

Q40042183-122E41DC-7090-407E-8F42-C1F048F6032C

P5875

Q40042183-2B385C9B-48DF-4B3D-BED2-B9279A391C41

P698

Q40042183-4305F757-1990-4FE2-B342-822DA81ECB55

P921

Q40042183-4CDA5703-CC75-45DB-A8D3-4541AAEE36A7

Q40042183-6FB6D983-8CE8-4B38-9F5B-5CC11E3D4BD7

Q40042183-F2337F54-1D27-4F1C-98D3-378E505EC66C

P356

P1433

P1476

Central obesity as a precursor ...... e AusDiab study and Mauritius.

@en

P2093

Jonathan E Shaw

http://www.w3.org/2001/XMLSchema#string

K George M M Alberti

http://www.w3.org/2001/XMLSchema#string

Paul Z Zimmet

http://www.w3.org/2001/XMLSchema#string

Pierrot Chitson

http://www.w3.org/2001/XMLSchema#string

Richard A Sicree

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Obesity, Inflammation, and Insulin Resistance

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Adiponectin and metabolic syndrome.

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

P304

2707-2716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/OBY.2008.412

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Jaakko Tuomilehto

Edward J. Boyko

Stefan Söderberg

Adrian J. Cameron

P577

2008-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23286158

http://www.w3.org/2001/XMLSchema#string

P698

18820650

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome